Tuesday, April 28 Recap
Note – We believe this is the most up-to-date information available at this time, but it is subject to change as circumstances warrant. Also, all finalized resources can be found on the COVID-19 Resource Center page of Hall Render’s website.
Trump Administration Releases “Blueprint for Testing Plans and Rapid Response Programs”
- The Trump Administration issued a series of guidelines for testing and rapid response programs as the nation’s economy reopens.
CDC Updates Evaluation and Laboratory Testing Criteria
- The CDC updated its evaluation and laboratory testing criteria.
CMS Issues Letter for Clinicians Participating in MIPS
- CMS issued a letter to clinicians participating in the Merit-Based Incentive Payment System (“MIPS”) for the 2020 performance period.
From the FDA
- The FDA released Frequently Asked Questions on Emergency Use Authorizations for Medical Devices During the COVID-19 Pandemic.
Congressional Outlook
- House Majority Leader Steny Hoyer announced today that the House will not return to session on May 4. While the Senate is still scheduled to return on May 4, no coronavirus-related votes are expected.
For more information, please contact:
- John Williams III at (202) 370-9585 or jwilliams@wp.hallrender.com;
- Andrew Coats at (202) 370-9587 or acoats@wp.hallrender.com;
- Abby Kaericher at (202) 780-2989 or akaericher@wp.hallrender.com; or
- Your regular Hall Render attorney.
Hall Render’s attorneys and professionals continue to maintain the most up-to-date information and resources at our COVID-19 Resource page, through our 24/7 COVID‑19 Hotline at (317) 429-3900 or by contacting your regular Hall Render attorney.
Hall Render blog posts and articles are intended for informational purposes only. For ethical reasons, Hall Render attorneys cannot—outside of an attorney-client relationship—answer specific questions that would be legal advice.
